P.M. Woollard
About
P.M. Woollard is a scholar working on Molecular Biology, Social Psychology and Spectroscopy.
According to data from OpenAlex, P.M. Woollard has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Social Psychology and 6 papers in Spectroscopy. Recurrent topics in P.M. Woollard's work include Neuroendocrine regulation and behavior (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Organic and Inorganic Chemical Reactions (4 papers). P.M. Woollard is often cited by papers focused on Neuroendocrine regulation and behavior (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Organic and Inorganic Chemical Reactions (4 papers). P.M. Woollard collaborates with scholars based in United Kingdom, Thailand and United States. P.M. Woollard's co-authors include R.D.R. Camp, Susan D. Brain, Malcolm W. Greaves, A. Kobza Black, A. I. Mallet, Robin Russell Jones, Fiona Cunningham, M.W. Greaves, Michael Allen and Kevin B. Bacon and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and British Journal of Pharmacology.
In The Last Decade
P.M. Woollard
25 papers receiving 1.1k citations
Peers
P.M. Woollard
Giichi Goto Japan
E. Schillinger Germany
David G. Ahern United States
G. Engelhardt Germany
Danielle Denis Canada
Chi‐Chung Chan Canada
Kang Cheng United States
Aaron T. Jacobs United States
Dwight Macdonald Canada
Paul M. Epstein United States
Citations per year, relative to P.M. Woollard P.M. Woollard (= 1×)
peers
Giichi Goto
Countries citing papers authored by P.M. Woollard
Since
Specialization
Citations
This map shows the geographic impact of P.M. Woollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M. Woollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M. Woollard more than expected).
Fields of papers citing papers by P.M. Woollard
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by P.M. Woollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M. Woollard. The network helps show where P.M. Woollard may publish in the future.
Co-authorship network of co-authors of P.M. Woollard
This figure shows the co-authorship network connecting the top 25 collaborators of P.M. Woollard. A scholar is included among the top collaborators of P.M. Woollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M. Woollard. P.M. Woollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Borthwick, Alan D., John Liddle, Anne M. Exall, et al.. (2012). Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency. Journal of Medicinal Chemistry. 55(2). 783–796.
2.
Holmes, Ian P., Olivier Lorthioir, Andrew H. Payne, et al.. (2010). The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure. Bioorganic & Medicinal Chemistry Letters. 20(6). 2013–2016.
3.
Ward, Simon E., Mark H Harries, Laura Aldegheri, et al.. (2010). Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of AMPA Receptor Positive Allosteric Modulators. Journal of Medicinal Chemistry. 54(1). 78–94.
4.
McCafferty, Gerald P., Mark Pullen, Charlene Wu, et al.. (2007). Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 293(1). R299–R305.
5.
Borthwick, Alan D., Anne M. Exall, Richard J. D. Hatley, et al.. (2006). 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo Potency. Journal of Medicinal Chemistry. 49(14). 4159–4170.
6.
Wyatt, Paul G., Michael Allen, C. Gardner, et al.. (2002). Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives. Bioorganic & Medicinal Chemistry Letters. 12(10). 1405–1411.
7.
Wyatt, Paul G., Michael Allen, Alison J. Foster, et al.. (2002). Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives. Bioorganic & Medicinal Chemistry Letters. 12(10). 1399–1404.
8.
Cockerill, Stuart, Colin Stubberfield, Jeremy N. Stables, et al.. (2001). Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2. Bioorganic & Medicinal Chemistry Letters. 11(11). 1401–1405.
9.
Jandu, Karamjit S., D. Cambridge, Christopher Foster, et al.. (2001). Discovery of 4-[3-(trans-3-Dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]- (4S)-oxazolidin-2-one (4991W93), a 5HT1B/1DReceptor Partial Agonist and a Potent Inhibitor of Electrically Induced Plasma Extravasation. Journal of Medicinal Chemistry. 44(5). 681–693.
10.
Wyatt, Paul G., et al.. (2001). Structure–activity relationship investigations of a potent and selective benzodiazepine oxytocin antagonist. Bioorganic & Medicinal Chemistry Letters. 11(10). 1301–1305.
11.
Woollard, P.M., et al.. (1991). Use of high-performance liquid chromatography— thermospray mass spectrometry and gas chromatography— electron-impact mass spectrometry in the identification of the metabolites of α-methylacetohydroxamic acids, potential anti-asthmatic agents. Journal of Chromatography B Biomedical Sciences and Applications. 562(1-2). 249–256.
12.
Bacon, Kevin B., R.D.R. Camp, Fiona Cunningham, & P.M. Woollard. (1988). Contrasting in vitro lymphocyte chemotactic activity of the hydroxyl enantiomers of 12‐hydroxy‐5,8,10,14‐eicosatetraenoic acid. British Journal of Pharmacology. 95(3). 966–974.
13.
Camp, R.D.R., F.M. Cunningham, N.J. Fincham, et al.. (1988). Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids. British Journal of Pharmacology. 94(4). 1043–1050.
14.
Carey, F., et al.. (1987). Identification and measurement of 12-hydroxy-5,8,10,14-eicosatetraenoic acid in whole blood: implications for the radioimmunoassay of leukotriene B4. Biochemical Society Transactions. 15(3). 430–431.
15.
Cunningham, F.M., Elizabeth Wong, P.M. Woollard, & Malcolm W. Greaves. (1986). The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products. Archives of Dermatological Research. 278(4). 270–273.
16.
Woollard, P.M.. (1986). Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochemical and Biophysical Research Communications. 136(1). 169–176.
17.
Camp, R.D.R., A. I. Mallet, Fiona Cunningham, et al.. (1985). The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasis. British Journal of Dermatology. 113(s28). 98–103.
18.
Dowd, Pauline M., A. Kobza Black, P.M. Woollard, R.D.R. Camp, & Malcolm W. Greaves. (1985). Cutaneous Responses to 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid (12-HETE). Journal of Investigative Dermatology. 84(6). 537–541.
19.
Camp, R.D.R., Robin Russell Jones, Susan D. Brain, P.M. Woollard, & Malcolm W. Greaves. (1984). Production of Intraepidermal Microabscesses by Topical Application of Leukotriene B4. Journal of Investigative Dermatology. 82(2). 202–204.
20.
Hillier, Keith, Patrick J. Roberts, & P.M. Woollard. (1976). Catecholamine-stimulated prostaglandin synthesis in rat brain synaptosomes. British Journal of Pharmacology. 58(3). 426–427.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Giichi Goto Breakdown of academic impact, for papers by E. Schillinger Breakdown of academic impact, for papers by David G. Ahern Breakdown of academic impact, for papers by G. Engelhardt Breakdown of academic impact, for papers by Danielle Denis Breakdown of academic impact, for papers by Chi‐Chung Chan Breakdown of academic impact, for papers by Kang Cheng Breakdown of academic impact, for papers by Aaron T. Jacobs Breakdown of academic impact, for papers by Dwight Macdonald Breakdown of academic impact, for papers by Paul M. Epstein